DNA-Guided Nanoparticle Assemblies
Abstract
In some embodiments, DNA-capped nanoparticles are used to define a degree of crystalline order in assemblies thereof. In some embodiments, thermodynamically reversible and stable body-centered cubic (bcc) structures, with particles occupying <˜10% of the unit cell, are formed. Designs and pathways amenable to the crystallization of particle assemblies are identified. In some embodiments, a plasmonic crystal is provided. In some aspects, a method for controlling the properties of particle assemblages is provided. In some embodiments a catalyst is formed from nanoparticles linked by nucleic acid sequences and forming an open crystal structure with catalytically active agents attached to the crystal on its surface or in interstices.
Claims
exact text as granted — not AI-modified1 . A plasmonic crystal comprising:
a bio-inspired metamaterial displaying long-range three-dimensional crystalline order, the metamaterial comprising a plurality of nano-objects of types one and two, the nano-objects of type one functionalized with a first nucleic acid sequence comprising a linking region and a spacer region, wherein at least one segment of spacer region is double-stranded, the nano-objects of type two functionalized with a second nucleic acid sequence comprising a linking region and a spacer region, the functionalized nano-objects linked by hybridization of their respective linking regions, the linked nano-objects assembled into a non-close-packed crystal structure.
2 . The plasmonic crystal of claim 1 , wherein:
the linking regions of the nano-objects of types one and two are non-interacting; the functionalized nano-objects are linked by hybridization of their respective linking regions with first and second recognition regions of a third nucleic acid sequence; the first recognition region complementary to the linking region of the nano-objects of type one; and the second recognition region complementary to the linking region of the nano-objects of type two.
3 . The plasmonic crystal of claim 1 , wherein the first and second nucleic acid sequences comprise sequences of PNA.
4 . The plasmonic crystal of claim 1 , wherein the first and second nucleic acid sequences are chosen from the group consisting of sequences of DNA, sequences of RNA, and sequences of RNA and sequences of DNA.
5 . The plasmonic crystal of claim 1 , wherein the metamaterial has a body-centered cubic crystal structure.
6 . The plasmonic crystal of claim 1 , wherein the functionalized nano-objects comprise less than about 10% of the volume of the crystal.Join the waitlist — get patent alerts
Track US2013261292A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.